The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man.
D000818:Animals; D000963:Antimetabolites / Q000633:toxicity*; D000970:Antineoplastic Agents / Q000633:toxicity*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D004285:Dogs; D005132:Eye Manifestations; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D000882:Haplorhini; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008206:Lymphatic Diseases / Q000139:chemically induced; D008231:Lymphopenia / Q000139:chemically induced; D008722:Methods; D009461:Neurologic Manifestations; D012140:Respiratory Tract Diseases / Q000139:chemically induced; D012877:Skin Manifestations
D000963:Antimetabolites; D000970:Antineoplastic Agents